These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1234 related articles for article (PubMed ID: 32865380)

  • 1. Colchicine in Patients with Chronic Coronary Disease.
    Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu XF; Ireland MA; Lenderink T; Latchem D; Hoogslag P; Jerzewski A; Nierop P; Whelan A; Hendriks R; Swart H; Schaap J; Kuijper AFM; van Hessen MWJ; Saklani P; Tan I; Thompson AG; Morton A; Judkins C; Bax WA; Dirksen M; Alings M; Hankey GJ; Budgeon CA; Tijssen JGP; Cornel JH; Thompson PL;
    N Engl J Med; 2020 Nov; 383(19):1838-1847. PubMed ID: 32865380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
    Opstal TSJ; Fiolet ATL; van Broekhoven A; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Duyvendak M; van Eck JWM; van Beek EA; den Hartog F; Budgeon CA; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH;
    J Am Coll Cardiol; 2021 Aug; 78(9):859-866. PubMed ID: 34446156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    Bhatt DL; Steg PG; Miller M; Brinton EA; Jacobson TA; Ketchum SB; Doyle RT; Juliano RA; Jiao L; Granowitz C; Tardif JC; Ballantyne CM;
    N Engl J Med; 2019 Jan; 380(1):11-22. PubMed ID: 30415628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
    Nissen SE; Lincoff AM; Brennan D; Ray KK; Mason D; Kastelein JJP; Thompson PD; Libby P; Cho L; Plutzky J; Bays HE; Moriarty PM; Menon V; Grobbee DE; Louie MJ; Chen CF; Li N; Bloedon L; Robinson P; Horner M; Sasiela WJ; McCluskey J; Davey D; Fajardo-Campos P; Petrovic P; Fedacko J; Zmuda W; Lukyanov Y; Nicholls SJ;
    N Engl J Med; 2023 Apr; 388(15):1353-1364. PubMed ID: 36876740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darapladib for preventing ischemic events in stable coronary heart disease.
    ; White HD; Held C; Stewart R; Tarka E; Brown R; Davies RY; Budaj A; Harrington RA; Steg PG; Ardissino D; Armstrong PW; Avezum A; Aylward PE; Bryce A; Chen H; Chen MF; Corbalan R; Dalby AJ; Danchin N; De Winter RJ; Denchev S; Diaz R; Elisaf M; Flather MD; Goudev AR; Granger CB; Grinfeld L; Hochman JS; Husted S; Kim HS; Koenig W; Linhart A; Lonn E; López-Sendón J; Manolis AJ; Mohler ER; Nicolau JC; Pais P; Parkhomenko A; Pedersen TR; Pella D; Ramos-Corrales MA; Ruda M; Sereg M; Siddique S; Sinnaeve P; Smith P; Sritara P; Swart HP; Sy RG; Teramoto T; Tse HF; Watson D; Weaver WD; Weiss R; Viigimaa M; Vinereanu D; Zhu J; Cannon CP; Wallentin L
    N Engl J Med; 2014 May; 370(18):1702-11. PubMed ID: 24678955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    Ridker PM; Everett BM; Thuren T; MacFadyen JG; Chang WH; Ballantyne C; Fonseca F; Nicolau J; Koenig W; Anker SD; Kastelein JJP; Cornel JH; Pais P; Pella D; Genest J; Cifkova R; Lorenzatti A; Forster T; Kobalava Z; Vida-Simiti L; Flather M; Shimokawa H; Ogawa H; Dellborg M; Rossi PRF; Troquay RPT; Libby P; Glynn RJ;
    N Engl J Med; 2017 Sep; 377(12):1119-1131. PubMed ID: 28845751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial.
    Heijman MWJ; Fiolet ATL; Mosterd A; Tijssen JGP; van den Bemt BJF; Schut A; Eikelboom JW; Thompson PL; van den Ende CHM; Nidorf SM; Popa CD; Cornel JH
    Ann Intern Med; 2023 Jun; 176(6):737-742. PubMed ID: 37247416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
    Tong DC; Quinn S; Nasis A; Hiew C; Roberts-Thomson P; Adams H; Sriamareswaran R; Htun NM; Wilson W; Stub D; van Gaal W; Howes L; Collins N; Yong A; Bhindi R; Whitbourn R; Lee A; Hengel C; Asrress K; Freeman M; Amerena J; Wilson A; Layland J
    Circulation; 2020 Nov; 142(20):1890-1900. PubMed ID: 32862667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    Ridker PM; Everett BM; Pradhan A; MacFadyen JG; Solomon DH; Zaharris E; Mam V; Hasan A; Rosenberg Y; Iturriaga E; Gupta M; Tsigoulis M; Verma S; Clearfield M; Libby P; Goldhaber SZ; Seagle R; Ofori C; Saklayen M; Butman S; Singh N; Le May M; Bertrand O; Johnston J; Paynter NP; Glynn RJ;
    N Engl J Med; 2019 Feb; 380(8):752-762. PubMed ID: 30415610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
    O'Donoghue ML; Braunwald E; White HD; Lukas MA; Tarka E; Steg PG; Hochman JS; Bode C; Maggioni AP; Im K; Shannon JB; Davies RY; Murphy SA; Crugnale SE; Wiviott SD; Bonaca MP; Watson DF; Weaver WD; Serruys PW; Cannon CP; ; Steen DL
    JAMA; 2014 Sep; 312(10):1006-15. PubMed ID: 25173516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    Manson JE; Cook NR; Lee IM; Christen W; Bassuk SS; Mora S; Gibson H; Gordon D; Copeland T; D'Agostino D; Friedenberg G; Ridge C; Bubes V; Giovannucci EL; Willett WC; Buring JE;
    N Engl J Med; 2019 Jan; 380(1):33-44. PubMed ID: 30415629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    Manson JE; Cook NR; Lee IM; Christen W; Bassuk SS; Mora S; Gibson H; Albert CM; Gordon D; Copeland T; D'Agostino D; Friedenberg G; Ridge C; Bubes V; Giovannucci EL; Willett WC; Buring JE;
    N Engl J Med; 2019 Jan; 380(1):23-32. PubMed ID: 30415637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
    Gibson CM; Duffy D; Korjian S; Bahit MC; Chi G; Alexander JH; Lincoff AM; Heise M; Tricoci P; Deckelbaum LI; Mears SJ; Nicolau JC; Lopes RD; Merkely B; Lewis BS; Cornel JH; Trebacz J; Parkhomenko A; Libby P; Sacks FM; Povsic TJ; Bonaca M; Goodman SG; Bhatt DL; Tendera M; Steg PG; Ridker PM; Aylward P; Kastelein JJP; Bode C; Mahaffey KW; Nicholls SJ; Pocock SJ; Mehran R; Harrington RA;
    N Engl J Med; 2024 May; 390(17):1560-1571. PubMed ID: 38587254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
    Fowkes FG; Price JF; Stewart MC; Butcher I; Leng GC; Pell AC; Sandercock PA; Fox KA; Lowe GD; Murray GD;
    JAMA; 2010 Mar; 303(9):841-8. PubMed ID: 20197530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.